A new study explores how the extreme biology of pythons may point to an unexpected path for obesity research. Pythons don’t nibble. They chomp, squeeze, and swallow their prey whole in a meal that can ...

Every time a Burmese python swallows a meal, something remarkable happens inside its body. Its heart expands by a quarter.

The key to healthier weight loss drugs could be found somewhere unexpected: inside a python’s blood. The slithering serpents ...

A post‑meal compound found in python blood curbed appetite in lab mice, hinting at future weight loss therapies.

At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three Philadelphians are living ...

Weight-loss programs abound on the internet, from customized plans sold by influencers lacking credentials to subscription services offering access to GLP-1s and other medications. It can be tricky to ...

Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested. The research, which was published in The BMJ, found that stopping the ...

Compared with cessation of behavioral weight management programs, weight regain was faster after cessation of medications (by 0.3 kg/month), independent of initial weight loss. HealthDay News — ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. The list of health benefits from weight loss ...

PUEBLO, Colo. (KOAA) — A historic pool in Pueblo will be converted into a space to help expand a one-of-a kind program with kids' safety in mind. The Mariposa Center for Safety is expanding its ...

If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...

When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...